Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study [Phase 1, Phase 2]
A Phase 1/2a clinical trial evaluating a new adjuvant vaccine for newly diagnosed glioblastoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma [Phase 1]
Phase 1 trial evaluating the combination of ruxolitinib with radiation and temozolomide for grade III gliomas and glioblastoma; the study is…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Clinical Significance of Liquid Biopsy in Brain Tumor Patients: a 5-ALA Guided Approach
Clinical trial update on the clinical significance of liquid biopsy in brain tumor patients using a 5-ALA guided approach; the study is curr…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations [Phase 2]
This Clinical Trial Update reports on a Phase 2 study of olaparib in patients with advanced glioma, cholangiocarcinoma, or other IDH1/IDH2-m…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Surgery and Laser Interstitial Thermal Therapy for Bilateral Glioblastomas [NA]
Clinical trial exploring surgery plus laser interstitial thermal therapy for bilateral glioblastoma, currently not yet recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma [Phase 3]
A Phase 3 clinical trial is evaluating PH weighted chemical exchange saturation transfer MRI-guided surgical resection to improve survival i…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors [Phase 1, Phase 2]
Clinical Trial Update on an ongoing Phase 1/2 study of allogeneic NK cells (EBNK-001) with low-dose interleukin-15, with or without pembroli…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update details a biomarker-guided allogeneic CAR-NK cell therapy using single-target or dual-target constructs for advan…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Liquid Biopsy in Glioblastoma Treated With Chemoradiation and an Oxygen Therapeutic
An ongoing clinical trial from NuvOx LLC is evaluating liquid biopsy approaches in glioblastoma patients treated with chemoradiation and an …
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial Tumors
This clinical trial update indicates the study analyzing cerebrospinal fluid leakage after intracranial tumor surgery is currently recruitin…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Surgical Nivolumab And Ipilimumab For Recurrent GBM [Phase 1]
A Phase 1 clinical trial update describes the surgical administration of nivolumab and ipilimumab for recurrent glioblastoma, with the study…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression [Phase 1]
A Phase 1 prospective surgical study examining whether patterns of electrical activity in high-grade glioma can predict disease progression.
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study [Phase 3]
A randomized phase III trial evaluating lomustine with or without reirradiation for first progression of glioblastoma. The study is currentl…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 Trial [Phase 2]
A Phase 2 clinical trial is evaluating the combination of trimipramine, atezolizumab, and bevacizumab in patients with recurrent glioblastom…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma [NA]
A clinical trial update indicates a study evaluating tumor and plasma biomarkers of response to TTFields in newly diagnosed glioblastoma is …
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Phase I Trial of pH Resections of GBM at VA [Phase 1]
A Phase I clinical trial evaluating pH resections for glioblastoma at the VA is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
GT Medical Technologies reports that the STaRT GammaTiles brain tumor trial is currently recruiting patients with various brain tumors, incl…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma [Phase 2]
This clinical trial update describes a Phase 2 study evaluating N-803 combined with PD-L1 t-haNK and bevacizumab for recurrent or progressiv…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies [NA]
This clinical trial update notes a Mayo Clinic-sponsored feasibility study on intraoperative microdialysis during neurosurgery for central n…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma [Phase 2]
Phase 2b trial evaluating a combination immunotherapy for newly diagnosed glioblastoma is currently active but not recruiting. Sponsor is Im…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: A Study Evaluating Temferon in Patients With Glioblastoma & Unmethylated MGMT [Phase 1, Phase 2]
Genenta Science is conducting a Phase 1/2 study of Temferon in glioblastoma patients, including those with unmethylated MGMT; the trial is a…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Panitumumab-IRDye800 for fluorescence-guided diagnosis in patients with malignant glioma undergoing su…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1-2 study of ST101 in patients with advanced solid tumors, including glioblastoma and melanoma. The trial is currently active but not …
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Evaluation of the CONVIVO System [NA]
The CONVIVO System is currently recruiting for a clinical trial evaluating its use in brain tumor surgery. It targets glioblastoma, glioma, …
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Imaging Acetadote Metabolism in Glioblastoma [EARLY_Phase 1]
A clinical trial update describes an early-phase 1 study imaging the metabolism of Acetadote (N-acetylcysteine) in glioblastoma; the trial i…